Media Release


Delisting of IGEA Pharma N.V., Hoofddrop NL

On 26 June 2023, SIX Exchange Regulation AG (SER) submitted a request to the Regulatory Board of SIX Group AG for the delisting of all registered shares of IGEA Pharma N.V. (Swiss Security Number 41’217’478 / ISIN NL0012768675) with a nominal value of EUR 0.01 each listed on SIX Swiss Exchange AG pursuant to Art. 58 para. 1 ciph. 2 Listing Rules (LR) due to the issuer’s solvency being in serious doubt. The Regulatory Board approved the delisting by decision of 3 July 2023. The delisting will take place on 6 November 2023, the last trading day at SIX Swiss Exchange AG will be on 3 November 2023.

The delisting decision is not legally binding yet and can be appealed to the Appeals Board within 20 trading days.

The decision regarding the delisting of IGEA Pharma N.V. is available on the Website of SER.

The applicable directive is available at the following link.